Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection

Abstract Background Refractory Helicobacter pylori (H. pylori) infection inevitably increase the difficulty of drug selection. Here, we described our experience with the use of a novel tetravalent IgY against H. pylori for the treatment of patients with refractory H. pylori infection. Methods Patien...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Nan Hao, Bo Liu, Meng Zhao, Mingming Lu, Feiyi Chen, Jialu Kang, Xiaojun Tang, Yong Zhang, Chengxue Dang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-06-01
Edice:	BMC Infectious Diseases
Témata:	Helicobacter pylori Refractory Tetravalent IgY Eradication Real-world
On-line přístup:	https://doi.org/10.1186/s12879-024-09498-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!